Huber needles are hollow needles that have slant tips to make it easy to go through the skin. Huber needles are used in chemotherapy, drug delivery, transfusions and blood samplings through the implanted port septum which is surgically rooted into the skin. They come in several sizes to fit the patient. With a Huber needle, the patient does not have to endure multiple needle sticks. They also protect clinicians from needle stick injuries.
Huber needles are off two types: straight Huber needles and curved Huber needles. The straight needles are mostly used in administration of injections. Curved needles are used in administration of nutritional fluids, chemotherapy fluids and medications like antibiotics.
Download Sample @ http://www.persistencemarketresearch.com/samples/3291
The global Huber needle market is categorized based on their types, therapeutic applications and by end users. The type segment is further sub-segmented into straight and curved. The therapeutic segment includes chemotherapy, blood transfusions, dialysis and antibiotics administration. The end user segment is further sub-segmented into academic colleges, general hospitals, public hospitals and cancer hospitals.
In terms of geographic, North America and Europe dominates the global Huber needles market due to increasing prevalence of breast cancer. The U.S. represents the largest market for Huber needles followed by Canada in North America. In Europe, France, Germany and Italy holds major share of Huber needle market. However, Asia is expected to show high growth rates in the next five years in global Huber needle market due to rising awareness among people towards cancers and their treatment. China and India are expected to be the fastest growing Huber needle market in Asia. In Latin America, Brazil is the largest market for Huber needles. Brazil has the largest private health insurance compared to other Latin American countries. The expansion of private health insurance in the country has increases the demand of medical equipments for better healthcare services.
Request TOC (desk of content material), Figures and Tables of the report: http://www.persistencemarketresearch.com/toc/3291
In recent time, increasing prevalence of cancer is key driving factor for the global Huber needle market. For instance, according to the International Agency for Research on Cancer (IARC), a specialized agency of the WHO, an estimated 12.7 million new cancer cases were reported in 2008 and the number reached 14.1 million in 2012. This increasing prevalence of cancer has resulted in significant rise in the demand of Huber needles for their chemotherapy treatment. In addition, advanced features of Huber needles is also supporting in growth of the global Huber needle market. However, high risks of complications associated with administration of drug delivery by Huber needles obstruct the growth of the global Huber needle market.
Some of the major companies operating in the global Huber needle market are B. Braun Medical, C. R. Bard, Perouse, Thiebaud, Smiths Medical and Vygon.
Browse Full Report@ http://www.persistencemarketresearch.com/market-research/huber-needle-market.asp
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.
Persistence Market Research Pvt. Ltd
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353